Payer PolicyActive
Thermal Perfusion Probe for Monitoring Regional Cerebral Blood Flow
AETNA-CPB-0703
Aetna
Effective: September 20, 2023
Updated: December 6, 2025
created · Dec 2, 2025
Policy Summary
Aetna considers thermal perfusion probes for monitoring regional cerebral blood flow investigational and not a covered/medically necessary service, excluding their use for acute neurologic disorders (e.g., head injury, subarachnoid hemorrhage, post‑neurosurgery) and for the listed ICD‑10 codes. Key requirement: prospective randomized clinical outcome evidence demonstrating clinical benefit is lacking, so the technology remains experimental/investigational and non‑covered.
Coverage Criteria Preview
Key requirements from the full policy
"Aetna considers a thermal perfusion probe for monitoring regional cerebral blood flow experimental and investigational because there is insufficient evidence of the clinical value of these approach..."
Sign up to see full coverage criteria, indications, and limitations.